ONCS Good Data likely to be presented and ONCS is a potential gapper pre-Market. Beside upcoming DATA ONCS will likely to provide updates relating Merck Partnership and more 2 Catalysts the near future.
"new clinical data on ImmunoPulse IL-12 will be presented on October 19 in Brisbane, Australia at the 9th World Congress of Melanoma". This presentation will occur overnight U.S. time. Given that, I would not be surprised to see a PR late today or before the market opens tomorrow.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.